Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaverine for Shortening Labor Duration After Cervical Ripening
NCT07237880Recruiting
- Sponsor
- Hillel Yaffe Medical Center
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in induced labor comparing Papaverine with Placebo Comparator (2 arms). Primary endpoint: Time from study drug administration to complete cervical dilation up to 24 hours. Started Apr 2025; status: recruiting.
02
Drugs
papaverine
03
Conditions
induced labor
Beyond the preview
Go deeper on NCT07237880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07237880.